NLTX
Price:
$3.49
Market Cap:
$8.20M
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-03-07
Stock Exchange
NASDAQ
Ticker
NLTX
According to Neoleukin Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6333315.00. This represents a change of -104.65% compared to the average of 136.34M of the last 4 quarters.
The mean historical Enterprise Value of Neoleukin Therapeutics, Inc. over the last ten years is 845.10M. The current -6333315.00 Enterprise Value has changed -174.94% with respect to the historical average. Over the past ten years (40 quarters), NLTX's Enterprise Value was at its highest in in the June 2020 quarter at 3.16B. The Enterprise Value was at its lowest in in the December 2022 quarter at 86.74M.
Average
845.10M
Median
761.54M
Minimum
86.61M
Maximum
2.74B
Discovering the peaks and valleys of Neoleukin Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 842.44%
Maximum Annual Enterprise Value = 2.74B
Minimum Annual Increase = -90.70%
Minimum Annual Enterprise Value = 86.61M
Year | Enterprise Value | Change |
---|---|---|
2022 | 86.61M | -90.70% |
2021 | 931.72M | -66.03% |
2020 | 2.74B | 130.43% |
2019 | 1.19B | 842.44% |
2018 | 126.29M | -87.99% |
2017 | 1.05B | -13.52% |
2016 | 1.22B | 105.54% |
2015 | 591.35M | 141.26% |
2014 | 245.12M | -9.45% |
2013 | 270.68M | -2.42% |
The current Enterprise Value of Neoleukin Therapeutics, Inc. (NLTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.25B
5-year avg
1.02B
10-year avg
845.10M
Neoleukin Therapeutics, Inc.’s Enterprise Value is less than CytomX Therapeutics, Inc. (62.24M), less than Spero Therapeutics, Inc. (12.49M), less than Instil Bio, Inc. (171.51M), less than NextCure, Inc. (25.04M), less than Assembly Biosciences, Inc. (90.35M), greater than Achilles Therapeutics plc (-61068820.00), less than Nuvation Bio Inc. (947.94M),
Company | Enterprise Value | Market cap |
---|---|---|
62.24M | $93.74M | |
12.49M | $71.07M | |
171.51M | $92.68M | |
25.04M | $39.73M | |
90.35M | $107.81M | |
-61068820.00 | $29.58M | |
947.94M | $692.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neoleukin Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neoleukin Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Neoleukin Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Neoleukin Therapeutics, Inc. (NLTX)?
What is the 3-year average Enterprise Value for Neoleukin Therapeutics, Inc. (NLTX)?
What is the 5-year average Enterprise Value for Neoleukin Therapeutics, Inc. (NLTX)?
How does the current Enterprise Value for Neoleukin Therapeutics, Inc. (NLTX) compare to its historical average?